Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 17

1.

Selectivity determinants of the aldose and aldehyde reductase inhibitor-binding sites.

El-Kabbani O, Podjarny A.

Cell Mol Life Sci. 2007 Aug;64(15):1970-8. Review.

PMID:
17497245
2.

Erythrocyte sorbitol level as a predictor of the efficacy of epalrestat treatment for diabetic peripheral polyneuropathy.

Ando H, Takamura T, Nagai Y, Kaneko S; Kanazawa University Multicenter Diabetes Study Group.

J Diabetes Complications. 2006 Nov-Dec;20(6):367-70.

PMID:
17070440
3.
4.

High glucose-induced activation of the polyol pathway and changes of gene expression profiles in immortalized adult mouse Schwann cells IMS32.

Sango K, Suzuki T, Yanagisawa H, Takaku S, Hirooka H, Tamura M, Watabe K.

J Neurochem. 2006 Jul;98(2):446-58.

5.
6.

[Role of polyol pathway in pathogenesis of diabetic microangiopathy].

Nakamura J.

Nihon Rinsho. 2005 Jun;63 Suppl 6:52-61. Review. Japanese. No abstract available.

PMID:
15999685
7.

C-106T polymorphism in promoter of aldose reductase gene is a risk factor for diabetic nephropathy in type 2 diabetes patients with poor glycaemic control.

Gosek K, Moczulski D, Zukowska-Szczechowska E, Grzeszczak W.

Nephron Exp Nephrol. 2005;99(3):e63-7. Epub 2005 Jan 5.

PMID:
15637423
8.

Diabetes induced decrease in detrusor smooth muscle force is associated with oxidative stress and overactivity of aldose reductase.

Changolkar AK, Hypolite JA, Disanto M, Oates PJ, Wein AJ, Chacko S.

J Urol. 2005 Jan;173(1):309-13.

PMID:
15592102
9.

Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy.

Dagher Z, Park YS, Asnaghi V, Hoehn T, Gerhardinger C, Lorenzi M.

Diabetes. 2004 Sep;53(9):2404-11.

10.

Potential role for the sorbitol pathway in the meiotic dysfunction exhibited by oocytes from diabetic mice.

Colton SA, Downs SM.

J Exp Zool A Comp Exp Biol. 2004 May 1;301(5):439-48.

PMID:
15114651
11.

Contribution of polyol pathway to diabetes-induced oxidative stress.

Chung SS, Ho EC, Lam KS, Chung SK.

J Am Soc Nephrol. 2003 Aug;14(8 Suppl 3):S233-6. Review.

12.

Recent studies of aldose reductase enzyme inhibition for diabetic complications.

Suzen S, Buyukbingol E.

Curr Med Chem. 2003 Aug;10(15):1329-52. Review.

PMID:
12871133
13.

Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes.

Amano S, Yamagishi Si, Kato N, Inagaki Y, Okamoto T, Makino M, Taniko K, Hirooka H, Jomori T, Takeuchi M.

Biochem Biophys Res Commun. 2002 Nov 29;299(2):183-8.

PMID:
12437967
14.

Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy.

Kishi Y, Schmelzer JD, Yao JK, Zollman PJ, Nickander KK, Tritschler HJ, Low PA.

Diabetes. 1999 Oct;48(10):2045-51.

PMID:
10512372
16.

Highly selective aldose reductase inhibitors. 3. Structural diversity of 3-(arylmethyl)-2,4,5-trioxoimidazolidine-1-acetic acids.

Kotani T, Nagaki Y, Ishii A, Konishi Y, Yago H, Suehiro S, Okukado N, Okamoto K.

J Med Chem. 1997 Feb 28;40(5):684-94.

PMID:
9057855
17.

Acetyl-L-carnitine corrects the altered peripheral nerve function of experimental diabetes.

Lowitt S, Malone JI, Salem AF, Korthals J, Benford S.

Metabolism. 1995 May;44(5):677-80.

PMID:
7752919

Supplemental Content

Support Center